Your browser doesn't support javascript.
loading
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
Burns, Melissa A; Place, Andrew E; Stevenson, Kristen E; Gutiérrez, Alejandro; Forrest, Suzanne; Pikman, Yana; Vrooman, Lynda M; Harris, Marian H; Hunt, Sarah K; O'Brien, Jane E; Asselin, Barbara L; Athale, Uma H; Clavell, Luis A; Cole, Peter D; Gennarini, Lisa M; Kahn, Justine M; Kelly, Kara M; Laverdiere, Caroline; Leclerc, Jean-Marie; Michon, Bruno; Schorin, Marshall A; Sulis, Maria Luisa; Welch, Jennifer J G; Neuberg, Donna S; Sallan, Stephen E; Silverman, Lewis B.
Affiliation
  • Burns MA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Place AE; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Stevenson KE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Gutiérrez A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Forrest S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Vrooman LM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Harris MH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hunt SK; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • O'Brien JE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Asselin BL; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Athale UH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Clavell LA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Cole PD; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Gennarini LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kahn JM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kelly KM; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York.
  • Laverdiere C; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, Ontario, Canada.
  • Leclerc JM; Division of Pediatric Oncology, San Jorge Children's Hospital, San Juan, Puerto Rico.
  • Michon B; Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, Rutgers; Robert Wood Johnson School of Medicine, New Brunswick, New Jersey.
  • Schorin MA; Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Bronx, New York.
  • Sulis ML; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University, New York, New York.
  • Welch JJG; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo, Buffalo, New York.
  • Neuberg DS; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
  • Sallan SE; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
  • Silverman LB; Division of Hematology-Oncology, Centre Hospitalier Universite de Quebec, Quebec City, Quebec, Canada.
Pediatr Blood Cancer ; 68(1): e28719, 2021 01.
Article in En | MEDLINE | ID: mdl-33026184
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Neoplasm, Residual / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Neoplasm, Residual / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Type: Article